Industry
Medical - Instruments & Supplies
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
Loading...
Open
0.79
Mkt cap
5.2M
Volume
55K
High
0.79
P/E Ratio
-0.26
52-wk high
3.76
Low
0.76
Div yield
N/A
52-wk low
0.55
Portfolio Pulse from Benzinga Newsdesk
August 27, 2024 | 12:01 pm
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 12:50 pm
Portfolio Pulse from Benzinga Newsdesk
August 19, 2024 | 10:57 am
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 7:27 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 6:43 am
Portfolio Pulse from Benzinga Newsdesk
August 13, 2024 | 11:16 am
Portfolio Pulse from Avi Kapoor
July 26, 2024 | 5:26 pm
Portfolio Pulse from Benzinga Newsdesk
July 26, 2024 | 5:09 pm
Portfolio Pulse from Benzinga Newsdesk
July 26, 2024 | 12:01 pm
Portfolio Pulse from Avi Kapoor
July 25, 2024 | 6:12 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.